BioSpecifics Technologies Corp is a biopharmaceutical company. It is developing an injectable collagenase clostridium histolyticum for multiple indications which is marketed as XIAFLEX in the United States or Xiapex in Europe.
Stock Price Prediction
Update at 5:00pm EST
58.841 - 59.162
59.162 - 59.428
55.247 - 55.639
55.639 - 55.965
56.006 - 56.608
56.608 - 57.108
as of: 2020-01-24 4:30:14 PM
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.BSTC has closed below upper band by 44.6%. Bollinger Bands are 4.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
2019-11-12 Zacks: BioSpecifics Technologies Corp. (NASDAQ:BSTC) Given $90.00 Consensus Target Price by Analysts BioSpecifics Technologies Corp. (NASDAQ:BSTC) has been given a consensus broker rating score of 1.00 (Strong Buy) from the one brokers that provide coverage for the company, Zacks Investment Research reports. One research analyst has rated the stock with a strong buy rating. Analysts have set a 12 month consensus price target of $90.00 for the […]
2019-11-08 BioSpecifics Technologies (BSTC) Q3 Earnings and Revenues Beat Estimates BioSpecifics (BSTC) delivered earnings and revenue surprises of 13.33% and 6.57%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.